|
|
12:59:18 PM
 |
SmarTrend's Option Scanner Detects Unusual Activity in Mylan (MYL)
Comtex SmarTrend(R)
|
| |
|
8:16:00 AM
|
Traders Hedging Bets in Mylan as Put Volume Surges (MYL)
Comtex SmarTrend(R)
|
| |
|
|
|
8:35:57 AM
|
Research Reports on Mylan and Watson Pharmaceuticals - Generic DrugMakers Striving Successfully
Marketwire
|
| |
www.RothmanResearch.com provides members a complete scrutiny of the
drugs -- generic industry with thorough research on Mylan Inc.
(MYL) and Watson Pharmaceuticals Inc.
|
|
|
10:06:15 AM
|
Next Support Level for Mylan (MYL) is $17.00
Comtex SmarTrend(R)
|
| |
SmarTrend has detected shares of Mylan (MYL) have bearishly opened below the pivot of $17.36 today and have reached the first level of support of $17.17.
Should the shares continue to fall, we are monitoring the next support pivots of $17.00 and $16.64. Also, the shares should find initial resistance at the 50-day moving average of $17.69 and further resistance at the 200-day moving average of $19.22.
SmarTrend, our proprietary pattern recognition system, alerted subscribers to buy shares of Mylan on July 27, 2010 at $18.38. Since the call, the stock has risen -6.7%.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time.
|
|
Wednesday, August 18, 2010
|
|
|
6:15:22 AM
|
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Endo Pharmaceuticals
Comtex SmarTrend(R)
|
| |
Below are the top five companies in the Pharmaceuticals industry as measured by relative performance.
|
|
|
1:49:39 PM
|
Mylan (MYL) Approaches New Downside Target of $17.11
Comtex SmarTrend(R)
|
| |
SmarTrend has detected shares of Mylan (MYL) have bearishly opened below the pivot of $17.43 today and have reached the first level of support of $17.28.
Should the shares continue to fall, we are monitoring the next support pivots of $17.11 and $16.79. Also, the shares should find initial resistance at the 50-day moving average of $17.81 and further resistance at the 200-day moving average of $19.19.
SmarTrend, our proprietary pattern recognition system, alerted subscribers to buy shares of Mylan on July 27, 2010 at $18.38. Since the call, the stock has risen -6.1%.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time.
|
3:33:18 AM
|
Mylan Inc concludes add-on offering of USD300m senior notes
M2
|
| |
Speciality pharmaceutical company Mylan Inc (MYL) reported on
Friday the completion of a private placement of USD300m aggregate
principal amount of senior notes due 2020.
|
|
|
2:22:00 PM
|
Mylan Announces Completion of Add-On Offering of Senior Notes
PR Newswire
|
| |
Mylan Inc. (MYL) today announced that it has completed a private placement of $300 million aggregate principal amount of Senior Notes due 2020.
|
8:30:41 AM
|
Mylan Laboratories (MYL) Gets Very Positive 5 STARs Strong Buy Rating From S&P
FreshBrewedMedia
|
| |
Mylan Laboratories (MYL) closed yesterday at $17.45.
|
|
|
8:55:48 AM
|
Mylan Call Volume Up 12x as Traders Speculate On Higher Prices (MYL)
Comtex SmarTrend(R)
|
| |
Shares of Mylan (MYL) traded 2.5% higher yesterday, closing at $18.10. The stock has been drifting higher over the past nine trading days and is currently trading in a technical uptrend.
The call volume yesterday was 26,139 contracts, which is 12x the average daily volume of 2,095. Usually high call volume is an indicator that many investors are looking for higher prices in the near future.
SmarTrend’s analytics is currently bullish and has Mylan in a technical uptrend. We are now watching for any positive developments that could result in a new uptrend signal.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time.
|
|
|
1:45:52 PM
|
Mylan Laboratories (MYL) NewsBite - MYL Upgraded By Bernstein
FreshBrewedMedia
|
| |
Mylan Laboratories (MYL) was upgraded today by analysts at Bernstein and the stock is now at $18.09, up $0.44 (2.49%) on volume of 3,442,489 shares traded.
|
11:37:41 AM
|
SmarTrend's Option Scanner Detects Unusual Activity in Mylan (MYL)
Comtex SmarTrend(R)
|
| |
Shares of Mylan (MYL) are trading 1.5% higher today, recently trading at $17.92. The stock has been drifting lower over the past ten trading days but is currently trading in a technical uptrend.
The call volume today was 2,246 contracts, which is 1.1x the average daily volume of 2,095. Usually high call volume is an indicator that many investors are looking for higher prices in the near future.
SmarTrend’s analytics is currently bullish and has Mylan in a technical uptrend. We are now watching for any positive developments that could result in a new uptrend signal.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time.
|
9:11:40 AM
|
Analyst Upgrades for August 9th, 2010
Comtex SmarTrend(R)
|
| |
Story: Analyst upgrades 8/9/2010...HiSoft Technologies International (HSFT) initiated at Buy at UBS...
|
|
|
1:07:03 PM
|
Watch for Shares of Mylan (MYL) to Approach Support at $17.28
Comtex SmarTrend(R)
|
| |
SmarTrend has detected shares of Mylan (MYL) have bearishly opened below the pivot of $17.70 today and have reached the first level of support of $17.54.
Should the shares continue to fall, we are monitoring the next support pivots of $17.28 and $16.86. Also, the shares should find initial resistance at the 50-day moving average of $18.09 and further resistance at the 200-day moving average of $19.13.
SmarTrend, our proprietary pattern recognition system, alerted subscribers to buy shares of Mylan on July 27, 2010 at $18.38. Since the call, the stock has risen -4.6%.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time.
|
|
|
6:22:28 AM
|
Mylan Inc prices add-on offering of USD300m senior notes
M2
|
| |
Specialist pharmaceutical company Mylan Inc (MYL) said on Friday
that the company has priced a USD300m aggregate principal amount of
senior notes due 2020.
|
5:19:03 AM
|
S&P rates Mylan’s USD300m 7.875% 2020 notes increase at BB-
M2
|
| |
2 August 2010 - S&P on Friday maintained its BB- issue-level and 5
recovery ratings on US generic drugs maker Mylan Inc’s (MYL)
7.875% senior unsecured notes due 2020 after the company raised the
issue amount by USD300m (EUR229m) to USD1bn.
|
3:05:02 AM
|
Goldman handles US Mylan’s USD300m 2020 bond increase
M2
|
| |
2 August 2010 - US generic drug maker Mylan (MYL) on Friday
raised by USD300m (EUR229m) the amount of its existing ten-year bond
with Goldman Sach (GS) acting as the sole bookrunner, said Thomson
Reuters service IFR.
|
|
|
1:29:00 PM
|
Mylan Announces Pricing of Add-On Offering of Senior Notes
PR Newswire
|
| |
Mylan Inc. (MYL) today announced that it priced $300 million aggregate principal amount of Senior Notes due 2020 at an issue price of 105.5% with a coupon of 7.875%, or an effective yield to maturity of 7.087%.
|
12:00:42 PM
|
Mylan Laboratories (MYL) NewsBite - MYL Moves Lower on Downgrade
FreshBrewedMedia
|
| |
Mylan Laboratories (MYL) opened at $17.03.
|
8:56:43 AM
|
Analysts Downgrades for July 30 2010
Comtex SmarTrend(R)
|
| |
Colgate-Palmolive (CL) downgraded two notches to Neutral from Conviction Buy at Goldman Sachs...
|
6:37:06 AM
|
Mylan Inc plans add-on private placement of USD300m senior notes due 2020
M2
|
| |
Speciality pharmaceutical company Mylan Inc (MYL) stated on
Thursday that the company proposes to privately place USD300m in
aggregate principal amount of senior notes through a reopening of its
senior notes due 2020.
|
6:35:43 AM
|
Top 5 Companies in the Pharmaceuticals Industry With the Lowest Relative Performance (TEVA, MYL, VVU
Comtex SmarTrend(R)
|
| |
Below are the top five companies in the Pharmaceuticals industry as measured by lowest relative performance.
|
|
|
4:50:00 PM
|
Mylan Announces Proposed Add-On Private Placement of its Senior Notes Due 2020
PR Newswire
|
| |
Mylan Inc. (MYL) today announced that it intends to privately place $300 million in aggregate principal amount of senior notes through a reopening of its Senior Notes due 2020, subject to market and other conditions.
|
|
|
4:42:53 PM
|
Mylan Reports Inline Results and Narrows Guidance Range (MYL)
Comtex SmarTrend(R)
|
| |
|
4:15:00 PM
|
Mylan Reports Adjusted Diluted EPS of $0.37 for the Three Months Ended June 30, 2010
PR Newswire
|
| |
Mylan Inc. (MYL) today announced its financial results for the three and six months ended June 30, 2010.
|
